On Invalid Date, Insmed (NASDAQ: INSM) reported Q3 2023 earnings per share (EPS) of -$1.11, up 1.83% year over year. Total Insmed earnings for the quarter were -$158.93 million. In the same quarter last year, Insmed's earnings per share (EPS) was -$1.09.
As of Q4 2023, Insmed's earnings has grown year over year. Insmed's earnings in the past year totalled -$723.63 million.
What was INSM's revenue last quarter?
On Invalid Date, Insmed (NASDAQ: INSM) reported Q3 2023 revenue of $79.07 million up 16.75% year over year. In the same quarter last year, Insmed's revenue was $67.73 million.
What was INSM's revenue growth in the past year?
As of Q4 2023, Insmed's revenue has grown 15.95% year over year. This is 94.62 percentage points lower than the US Biotechnology industry revenue growth rate of 110.58%. Insmed's revenue in the past year totalled $280.82 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.